To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Quaker Bioventures closes $280m first fund
The Philadelphia firm’s new vehicle is focused on multi-stage life sciences companies and is the largest inaugural venture vehicle in the last year and half.
